Literature DB >> 27036161

A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.

Paulo Vidal Campregher1, Welbert de Oliveira Pereira2, Bianca Lisboa2, Renato Puga2, Elvira Rodrigues Pereira Velloso Deolinda3, Ricardo Helman4, Luciana Cavalheiro Marti2, João Carlos Campos Guerra5, Kalliopi N Manola6, Roberta Cardoso Petroni5, Alanna Mara Pinheiro Sobreira Bezerra5, Fernando Ferreira Costa7, Nelson Hamerschlak4, Fábio Pires de Souza Santos4.   

Abstract

Entities:  

Keywords:  acute myeloid leukemia; gene fusion; nucleophosmin

Mesh：

Substances：

Year:  2016        PMID： 27036161      PMCID： PMC5004474          DOI： 10.3324/haematol.2015.137364

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Authors:  Carolien M Woolthuis; André B Mulder; Rikst Nynke Verkaik-Schakel; Stefano Rosati; Arjan Diepstra; Eva van den Berg; Jan Jacob Schuringa; Edo Vellenga; Philip M Kluin; Gerwin Huls
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

2.  LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins.

Authors:  Darui Xu; Kara Marquis; Jimin Pei; Szu-Chin Fu; Tolga Cağatay; Nick V Grishin; Yuh Min Chook
Journal:  Bioinformatics       Date:  2014-12-15       Impact factor: 6.937

3.  Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

Authors:  Felicitas Thol; Frederik Damm; Andrea Lüdeking; Claudia Winschel; Katharina Wagner; Michael Morgan; Haiyang Yun; Gudrun Göhring; Brigitte Schlegelberger; Dieter Hoelzer; Michael Lübbert; Lothar Kanz; Walter Fiedler; Hartmut Kirchner; Gerhard Heil; Jürgen Krauter; Arnold Ganser; Michael Heuser
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

4.  FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution.

Authors:  Aaron M Newman; Scott V Bratman; Henning Stehr; Luke J Lee; Chih Long Liu; Maximilian Diehn; Ash A Alizadeh
Journal:  Bioinformatics       Date:  2014-08-20       Impact factor: 6.937

5.  Acute myeloid leukemia with t(5;18)(q35;q21).

Authors:  E S Wang; P Maslak; K Cathcart; J G Jurcic
Journal:  Cancer Genet Cytogenet       Date:  2001-05

6.  Translocation t(5;18)(q35;q21) as a rare nonrandom abnormality in acute myeloid leukemia.

Authors:  A Daraki; L K Bourantas; K N Manola
Journal:  Cytogenet Genome Res       Date:  2013-03-23       Impact factor: 1.636

7.  Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

Authors:  Brunangelo Falini; Niccolò Bolli; Jing Shan; Maria Paola Martelli; Arcangelo Liso; Alessandra Pucciarini; Barbara Bigerna; Laura Pasqualucci; Roberta Mannucci; Roberto Rosati; Paolo Gorello; Daniela Diverio; Giovanni Roti; Enrico Tiacci; Giovanni Cazzaniga; Andrea Biondi; Suzanne Schnittger; Torsten Haferlach; Wolfgang Hiddemann; Massimo F Martelli; Wei Gu; Cristina Mecucci; Ildo Nicoletti
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.

Authors:  Claudia Haferlach; Cristina Mecucci; Susanne Schnittger; Alexander Kohlmann; Marco Mancini; Antonio Cuneo; Nicoletta Testoni; Giovanna Rege-Cambrin; Antonella Santucci; Marco Vignetti; Paola Fazi; Maria Paola Martelli; Torsten Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

10.  A novel insertion ins(18;5)(q21.1;q31.2q35.1) in acute myeloid leukemia associated with microdeletions at 5q31.2, 5q35.1q35.2 and 18q12.3q21.1 detected by oligobased array comparative genomic hybridization.

Authors:  Eigil Kjeldsen
Journal:  Mol Cytogenet       Date:  2014-09-25       Impact factor: 2.009
View more
  4 in total

Review 1.  Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors:  Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal:  Biomark Res       Date:  2021-05-06

Review 2.  Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment.

Authors:  Tao Xu; Hongxiang Wang; Xiaoquan Huang; Weiqing Li; Qilin Huang; Yong Yan; Juxiang Chen
Journal:  Transl Oncol       Date:  2018-03-20       Impact factor: 4.243

3.  NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.

Authors:  Markéta Šašinková; Petr Heřman; Aleš Holoubek; Dita Strachotová; Petra Otevřelová; Dana Grebeňová; Kateřina Kuželová; Barbora Brodská
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

4.  Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.

Authors:  Maria Paola Martelli; Roberta Rossi; Alessandra Venanzi; Manja Meggendorfer; Vincenzo Maria Perriello; Giovanni Martino; Orietta Spinelli; Raffaella Ciurnelli; Emanuela Varasano; Lorenzo Brunetti; Stefano Ascani; Corinne Quadalti; Valeria Cardinali; Federica Mezzasoma; Ilaria Gionfriddo; Francesca Milano; Roberta Pacini; Alessia Tabarrini; Barbara Bigerna; Francesco Albano; Giorgina Specchia; Calogero Vetro; Francesco Di Raimondo; Ombretta Annibali; Giuseppe Avvisati; Alessandro Rambaldi; Franca Falzetti; Enrico Tiacci; Paolo Sportoletti; Torsten Haferlach; Claudia Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.